tci Medicare Compliance & Reimbursement - 2005 Issue 39

ENFORCEMENT WATCH: DOJ Chips Away At 'Double Dipping' Schemes

Best advice: Dip once and end it.Providers beware: The Department of Justice is paying even closer attention to the accuracy of providers' drug prices that impact Medicare and Medicaid payments. Reason: Pharmaceutical manufacturing giant GlaxoSmithKline has agreed to pay $150 million to settle allegations of fraudulent and inflated drug prices, the DOJ announced on Sept. 20. The company allegedly hatched a scheme to inflate its prices for Zofran and Kytril, causing federal healthcare programs to base their reimbursement rates on the incorrect prices, and thus, cause providers to submit false claims to Medicare and Medicaid.GlaxoSmithKline also...

To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.


Keep pace with evolving Medicare regulations — and onboard your team — with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI's Medicare Compliance & Reimbursement Alert will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, payer policies, the fee schedule, OIG target areas, and more.

  • Current newsletters added each month
  • Fully searchable archives - over 4200 articles
  • ALL years/issues back to 2003 organized by year and issue
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles
Access to this feature is available in the following products:
  • tci Medicare Compliance & Reimbursement +Archives

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.